Evidence map›Paper›PMID 38536225›Full record

Trial reportJournal of medical Internet research2024

Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.

Melissa Vereschagin, Angel Y Wang, Chris G Richardson, Hui Xie, Richard J Munthali, Kristen L Hudec, Calista Leung, Katharine D Wojcik, Lonna Munro, Priyanka Halli and 2 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of medical Internet research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05606601 (An Integrated Online Intervention Addressing Mental Health and Substance Use in University Students), which is not on this map. Cited by 15 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 5 pooled it
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05606601 nacompletednot on this map

An Integrated Online Intervention Addressing Mental Health and Substance Use in University Students: A Randomized Controlled Trial

TypeinterventionalSponsorUniversity of British ColumbiaRan2022 to 2023Enrolled1,489ConditionsAnxiety, Depression, Alcohol Use, Substance UseArmsMinder
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 5 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Melissa VereschaginDepartment of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-0378-3296
Angel Y WangDepartment of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0003-2001-2220
Chris G RichardsonSchool of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-7641-7027
Hui XieFaculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.ORCID 0000-0003-3328-7135
Richard J MunthaliDepartment of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0001-8492-7409
Kristen L HudecDepartment of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0001-8573-1491
Calista LeungDepartment of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0003-0016-3961
Katharine D WojcikMenninger Department of Psychiatry & Behavioural Sciences, Baylor College of Medicine, Houston, TX, United States.ORCID 0000-0003-4964-4248
Lonna MunroDepartment of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-8002-8008
Priyanka HalliDepartment of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-5806-6024
Ronald C KesslerDepartment of Health Care Policy, Harvard Medical School, Boston, MA, United States.ORCID 0000-0003-4831-2305
Daniel V VigoDepartment of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-4445-4122
University of British Columbia · CABaylor College of Medicine · USHarvard University · USSimon Fraser University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUniversity attendance represents a transition period for students that often coincides with the emergence of mental health and substance use challenges. Digital interventions have been identified as a promising means of supporting students due to their scalability, adaptability, and acceptability. Minder is a mental health and substance use mobile app that was codeveloped with university students.

objectiveThis study aims to examine the effectiveness of the Minder mobile app in improving mental health and substance use outcomes in a general population of university students.

methodsA 2-arm, parallel-assignment, single-blinded, 30-day randomized controlled trial was used to evaluate Minder using intention-to-treat analysis. In total, 1489 participants were recruited and randomly assigned to the intervention (n=743, 49.9%) or waitlist control (n=746, 50.1%) condition. The Minder app delivers evidence-based content through an automated chatbot and connects participants with services and university social groups. Participants are also assigned a trained peer coach to support them. The primary outcomes were measured through in-app self-assessments and included changes in general anxiety symptomology, depressive symptomology, and alcohol consumption risk measured using the 7-item General Anxiety Disorder scale, 9-item Patient Health Questionnaire, and US Alcohol Use Disorders Identification Test-Consumption Scale, respectively, from baseline to 30-day follow-up. Secondary outcomes included measures related to changes in the frequency of substance use (cannabis, alcohol, opioids, and nonmedical stimulants) and mental well-being. Generalized linear mixed-effects models were used to examine each outcome.

resultsIn total, 79.3% (589/743) of participants in the intervention group and 83% (619/746) of participants in the control group completed the follow-up survey. The intervention group had significantly greater average reductions in anxiety symptoms measured using the 7-item General Anxiety Disorder scale (adjusted group mean difference=-0.85, 95% CI -1.27 to -0.42; P<.001; Cohen d=-0.17) and depressive symptoms measured using the 9-item Patient Health Questionnaire (adjusted group mean difference=-0.63, 95% CI -1.08 to -0.17; P=.007; Cohen d=-0.11). A reduction in the US Alcohol Use Disorders Identification Test-Consumption Scale score among intervention participants was also observed, but it was not significant (P=.23). Statistically significant differences in favor of the intervention group were found for mental well-being and reductions in the frequency of cannabis use and typical number of drinks consumed. A total of 77.1% (573/743) of participants in the intervention group accessed at least 1 app component during the study period.

conclusionsIn a general population sample of university students, the Minder app was effective in reducing symptoms of anxiety and depression, with provisional support for increasing mental well-being and reducing the frequency of cannabis and alcohol use. These findings highlight the potential ability of e-tools focused on prevention and early intervention to be integrated into existing university systems to support students' needs.

trial registrationClinicalTrials.gov NCT05606601; https://clinicaltrials.gov/ct2/show/NCT05606601. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.2196/49364.

Indexed as

AlcoholismCannabisAnxiety DisordersGeneralized Anxiety DisorderHumansMental HealthUniversitiescollege studentsdigital interventionsmental healthmobile interventionsmobile phonerandomized controlled trialsubstance use

Identifiers

PMID38536225
PMCPMC11007604
OpenAlexW4393221331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.